Gene Review:
Alpk1 - alpha-kinase 1
Mus musculus
Synonyms:
8430410J10Rik, Alpha-protein kinase 1, Kiaa1527, LAK, Lak, ...
- Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells. Blottière, H.M., Zennadi, R., Grégoire, M., Aillet, G., Denis, M.G., Meflah, K., Le Pendu, J. Int. J. Cancer (1993)
- LAK cells release a novel form of directly acting TGF beta, tightly bound to a high molecular weight carrier(s). Larisch-Bloch, S., Sulitzeanu, D. Growth Factors (1993)
- Evaluation of the antitumor activity of human IL-4 by in vitro and in vivo assays. Wang, T., Chen, W. Chin. Med. Sci. J. (1994)
- Interleukin 2-antibody and tumor necrosis factor-antibody fusion proteins induce different antitumor immune responses in vivo. Christ, O., Matzku, S., Burger, C., Zöller, M. Clin. Cancer Res. (2001)
- The mechanism of IL-2-mediated protection against GVHD in mice. II. Protection occurs independently of NK/LAK cells. Sykes, M., Abraham, V.S. Transplantation (1992)
- Inactivity of methylene chloride in the mouse bone marrow micronucleus assay. Sheldon, T., Richardson, C.R., Elliott, B.M. Mutagenesis (1987)
- Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration. Basse, P.H., Herberman, R.B., Hokland, M.E., Goldfarb, R.H. Nat. Immun. (1992)
- Radioprotective effect of lyophyllum decastes and the effect on immunological functions in irradiated mice. Nakamura, T., Itokawa, Y., Tajima, M., Ukawa, Y., Cho, K.H., Choi, J.S., Ishid, T., Gu, Y. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan / sponsored by All-China Association of Traditional Chinese Medicine, Academy of Traditional Chinese Medicine (2007)
- Analysis of a murine anti-ganglioside GD2 monoclonal antibody expressing both IgG2a and IgG3 isotypes: monoclonality, apoptosis triggering, and activation of cellular cytotoxicity on human melanoma cells. Lin, C.C., Shen, Y.C., Chuang, C.K., Liao, S.K. Adv. Exp. Med. Biol. (2001)
- Induction of lymphokine-activated killer activity in mice by prothymosin alpha. Baxevanis, C.N., Gritzapis, A.D., Dedoussis, G.V., Papadopoulos, N.G., Tsolas, O., Papamichail, M. Cancer Immunol. Immunother. (1994)
- Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity. Frost, P., Ng, C.P., Belldegrun, A., Bonavida, B. Cell. Immunol. (1997)
- Differentiation of macrophage precursors to cells with LAK activity under the influence of CSF-1 and high dose IL-2. Li, H., Kniep, E., Emmendörffer, A., Lohmann-Matthes, M.L. Scand. J. Immunol. (1991)
- The preliminary observation on immunosuppressive effect of norcantharidin in mice. Yan, M.S., Xiue, S., Wei, L.X., Piao, X.H. Immunopharmacology and immunotoxicology. (1993)
- Role of natural killer and killer cells in concordant xenograft rejection. Patselas, T., Thomas, F., Araneda, D., Marchman, W. Transplant. Proc. (1995)
- Chemotherapy-induced modulation of natural killer and lymphokine-activated killer cell activity in euthymic and athymic mice. Gazit, Z., Kedar, E. Cancer Immunol. Immunother. (1994)
- Hexachloro-1,3-butadiene-induced hydropic change in mouse liver. Lock, E.A., Pratt, I.S., Ishmael, J. Journal of applied toxicology : JAT. (1985)
- In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states. Butler, L.D., Browne, C.P., Layman, N.K., Riedl, P., Tang, J., Marder, P., DeLong, D., Manetta, J., Bobbitt, L., Strnad, J. Cancer Res. (1988)
- Interleukin-2 antitumor and effector cell responses. Hawkins, M.J. Semin. Oncol. (1993)
- Demonstration of a splenic cytotoxic effector cell in mice of genotype SCID/SCID.BG/BG. MacDougall, J.R., Croy, B.A., Chapeau, C., Clark, D.A. Cell. Immunol. (1990)